Free Trial
NASDAQ:THTX

Theratechnologies (THTX) Stock Price, News & Analysis

Theratechnologies logo
$3.24 -0.01 (-0.31%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$3.24 +0.00 (+0.15%)
As of 08/29/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Theratechnologies Stock (NASDAQ:THTX)

Key Stats

Today's Range
$3.24
$3.25
50-Day Range
$2.30
$3.26
52-Week Range
$1.12
$3.27
Volume
584,158 shs
Average Volume
328,829 shs
Market Capitalization
$148.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Receive THTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

THTX Stock News Headlines

Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.tc pixel
Theratechnologies Inc. (THTX) - Yahoo Finance
See More Headlines

THTX Stock Analysis - Frequently Asked Questions

Theratechnologies' stock was trading at $1.81 at the beginning of 2025. Since then, THTX stock has increased by 79.0% and is now trading at $3.24.

Theratechnologies Inc. (NASDAQ:THTX) issued its earnings results on Wednesday, July, 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.08. The business earned $17.73 million during the quarter, compared to analysts' expectations of $24.30 million.

Theratechnologies's stock reverse split on the morning of Monday, July 31st 2023.The 1-4 reverse split was announced on Monday, July 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Theratechnologies subsidiaries include Katana, Pharma-G Inc., Theratechnologies Europe Inc., Theratechnologies Europe Limited, Theratechnologies Intercontinental Inc., and Theratechnologies U.S. Inc.

Theratechnologies' top institutional investors include AIGH Capital Management LLC (4.53%), Stonepine Capital Management LLC (0.41%), Alberta Investment Management Corp (0.33%) and Skandinaviska Enskilda Banken AB publ (0.29%).

Shares of THTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Theratechnologies investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), CymaBay Therapeutics (CBAY), Novo Nordisk A/S (NVO), Adobe (ADBE) and Celestica (CLS).

Company Calendar

Last Earnings
7/09/2025
Today
8/29/2025
Next Earnings (Estimated)
10/09/2025
Fiscal Year End
11/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:THTX
CIK
1512717
Employees
140
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
($0.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
324.50
P/E Growth
N/A
Net Income
-$8.31 million
Net Margins
-10.85%
Pretax Margin
-8.09%
Return on Equity
N/A
Return on Assets
-9.83%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.84
Quick Ratio
0.65

Sales & Book Value

Annual Sales
$85.87 million
Price / Sales
1.74
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.55) per share
Price / Book
-5.90

Miscellaneous

Outstanding Shares
45,980,000
Free Float
N/A
Market Cap
$149.21 million
Optionable
Optionable
Beta
0.52

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:THTX) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners